About

Roshan Kumar is the Head of Translational Medicine at HiFiBiO Therapeutics. He is a scientist with over 20 years of experience in the study of complex biological systems, with a focus on human immunology and immune-mediated disease. Roshan has been with HiFiBiO for more than a decade, where he has helped develop and apply the company’s single-cell and immune profiling platform to discover and advance a pipeline of immunomodulatory antibodies for autoimmune diseases and cancer. Roshan has also led HiFiBiO’s External Innovation where he has been responsible for the discovery and development of over 10 novel biotherapeutics under collaborations with MNCs. His current focus is on translating human immune biology into biomarker-driven insights that inform therapeutic strategy and early clinical development.

Roshan received a B.S. from the California Institute of Technology and Ph.D. in Biochemistry from the Scripps Research Institute. His postdoctoral studies were performed at the Whitehead Institute for Biological Research at MIT and the Wyss Institute for Biologically Inspired Engineering at Harvard Medical School.